Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of CP-4126 in Patients With Advanced Pancreatic Cancer.

NCT00913198 is registered in ClinicalTrials.gov with Clavis Pharma as lead sponsor.

NCT NCT00913198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00913198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of CP-4126 in Patients With Advanced Pancreatic Cancer.
Lead sponsor
Clavis Pharma
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2009
Completion date
September 30, 2011
Enrollment
21 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced adenocarcinoma of pancreas